Rep. Gilbert Ray Cisneros Jr. (D-CA) Buys Balchem (BCPC) Stock
Rep. Gilbert Ray Cisneros Jr. purchased shares of Balchem Corporation, valued between $1,001 and $15,000, on September 17, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
Rep. Gilbert Ray Cisneros Jr. (D-CA) bought between $1,001 and $15,000 of Balchem Corporation ($BCPC) stock on September 17, 2026. The trade was disclosed in a STOCK Act periodic transaction report filed October 12, 2026.
Since the trade, $BCPC is up 1.2% after 1 week and up 3.0% to date (from the $165.76 close on Sep 17, 2026).
Financial Disclosure Report
Clerk of the House of Representatives • Legislative Resource Center • B81 Cannon Building • Washington, DC 20515
Filer Information
- Name:
- Rep. Gilbert Ray Cisneros Jr. (D)
- Status:
- Member — House
- Party:
- Democrat
Filing Information
- Filing Type:
- Periodic Transaction Report
- Filing Year:
- 2026
- Filing Date:
- Oct 12, 2026
Schedule B: Transactions
| Asset | Transaction | Date | Amount |
|---|---|---|---|
| Balchem Corporation ($BCPC) | Buy | Sep 17, 2026 | $1,001 - $15,000 |
Summary of the filed report, not the original document. View the original: STOCK Act disclosure (House Clerk)
BCPC
Balchem Corporation
Key Points
- Gilbert Ray Cisneros Jr., a Democratic representative from California's 31st district, bought shares of Balchem Corporation between $1,001 and $15,000 on September 17, 2026.
- As of October 16, 2026, Balchem stock recently traded around $171.60, showing a solid performance in the specialty chemicals sector.
- Analysts maintain a 'Buy' rating on Balchem, with a price target of $215.00 set by HC Wainwright & Co. on August 3, 2026.
Get $BCPC trade alerts by text
We text you when insiders, Congress or big funds trade $BCPC. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Balchem Corporation alert may contain errors. Disclosures
Rep. Gilbert Ray Cisneros Jr., a Democrat from California's 31st district, bought shares of Balchem Corporation (NasdaqGS: BCPC) valued between $1,001 and $15,000 on September 17, 2026. This trade was disclosed in a periodic transaction report filed under the STOCK Act on October 12, 2026.
Gilbert Ray Cisneros Jr. vs. the S&P 500
Hypothetical returns from Gilbert Ray Cisneros Jr.'s disclosed trades, not real profit or advice. How we model this.
What Changed in Cisneros's Balchem Position
Cisneros's recent purchase adds to his portfolio in Balchem Corporation, a company that develops and sells specialty performance ingredients across various markets, including food and pharmaceuticals.
Other Institutional Activity in Balchem
Several institutional investors have shown activity in Balchem recently. Blackrock Inc. increased its stake by 122,974 shares, bringing its total to about 4.96 million shares valued at approximately $847.6 million. Vanguard Portfolio Management LLC added 27,856 shares, resulting in a total of about 2.22 million shares worth around $379.2 million. State Street Corporation also raised its holdings by 40,820 shares, totaling about 1.28 million shares valued at about $218.8 million.
Balchem Corporation Stock Up 2.2%
As of October 16, 2026, Balchem shares were recently trading around $171.60. This price is significant as it positions the stock well within the specialty chemicals sector, indicating investor confidence following recent analyst upgrades.
Recent Earnings
Balchem reported trailing twelve-month revenue of approximately $1.09 billion, with an impressive year-over-year revenue growth of 11.2%. The company's net margin stood at 15.1%, and it has a return on equity (ROE) of 12.8%. The next earnings report is scheduled for October 20, 2026.
Dividend
Balchem pays an annual dividend of $0.96 per share, with a payout ratio of 18.9%.
Insider Buying and Selling at Balchem Corporation
Insider trading activity includes Martin Luther Reid, an officer, who sold 1,200 shares on November 11, 2025, valued at about $185,328. Director David B Fischer sold 8,000 shares on December 3, 2025, totaling approximately $1.23 million. Additionally, officer Gunsteren Job Leonard Van sold 6,000 shares on December 4, 2025, valued at around $919,723.
Analysts Set New Price Targets
On August 3, 2026, HC Wainwright & Co. maintained a 'Buy' rating on Balchem with a price target of $215. This target reflects an increase from a prior target of $190. The consensus among analysts suggests a positive outlook for the stock, with significant growth potential.
About Balchem Corporation
Balchem Corporation, headquartered in Montvale, NJ, specializes in developing and distributing performance ingredients for various sectors, including nutrition and pharmaceuticals. Its diverse product range serves critical markets worldwide, making it a key player in the specialty chemicals industry.
Bottom Line
Investors should watch for Balchem's upcoming earnings report on October 20, 2026, for insights into its financial performance. This recent buy by Cisneros fits into a pattern of his trading activities, which include earlier sales and purchases of other stocks.
Related Filing Alerts
Source: Gilbert Ray Cisneros Jr.'s STOCK Act disclosure on $BCPC (Sep 17, 2026). Read the original filing: STOCK Act disclosure (House Clerk). Written by software, not financial advice. How we make alerts